Orion Biotech Opportunities Net Income

The latest net income for ORIA is $4.9T as of December 2022. That compares with $-1.4M in the prior-year period — up 346576301.9% year over year. That is above the sector sector average of $98M. Investors often review this figure alongside Orion Biotech Opportunities's historical trend and sector peers before judging valuation or financial health.

Over the past year, ORIA's net income moved from $-1.4M to $4.9T — a 346576301.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orion Biotech Opportunities's operating scale or balance-sheet position.

Against its sector companies, ORIA currently prints $4.9T for net income, while the sector average sits near $98M. That is roughly 5019828.7% above the sector mean. Large gaps often invite a closer look at Orion Biotech Opportunities's growth, margins, and balance sheet.

A net income figure of $4.9T for ORIA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $98M. Explore the charts below for those layers of context.

After noting ORIA's net income ($4.9T), review year-over-year change from $-1.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.